1. Home
  2. LTRX vs MIST Comparison

LTRX vs MIST Comparison

Compare LTRX & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantronix Inc.

LTRX

Lantronix Inc.

HOLD

Current Price

$5.55

Market Cap

199.5M

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$2.66

Market Cap

163.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRX
MIST
Founded
1989
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.5M
163.2M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
LTRX
MIST
Price
$5.55
$2.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$5.17
$6.33
AVG Volume (30 Days)
299.4K
3.5M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$118,294,000.00
N/A
Revenue This Year
$4.59
N/A
Revenue Next Year
$12.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$0.63
52 Week High
$5.89
$2.77

Technical Indicators

Market Signals
Indicator
LTRX
MIST
Relative Strength Index (RSI) 64.57 70.83
Support Level $4.88 $2.52
Resistance Level $5.89 $2.75
Average True Range (ATR) 0.31 0.19
MACD 0.09 0.03
Stochastic Oscillator 77.18 86.54

Price Performance

Historical Comparison
LTRX
MIST

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: